OR WAIT null SECS
May 31, 2023
The project is being coordinated by the recently formed not-for-profit CCRM Nordic AB and gathers engaged stakeholders to move the initiative forward.
May 23, 2023
uBriGene Biosciences will acquire Mustang Bio’s Worcester, Mass., CGT manufacturing facility in a deal worth up to $11 million, expanding its operations into the US market.
May 17, 2023
CATTI has launched an in-person training site at the University of Guelph in Ontario, Canada, for training personnel in cell and gene therapy manufacturing.
May 16, 2023
The first CleanCap analog was launched in 2017, and since then, the capping technology has been incorporated in one of the first commercially approved COVID-19 vaccines.
May 11, 2023
The objective of the partnership is to automate portions of ScaleReady’s CGT manufacturing workflow by using Cellular Origin’s robotic system for sterile liquid transfer.
May 03, 2023
mRNA therapeutics are being researched to support the fight against rare diseases, infectious viruses, and cancers.
The development of CAR-T therapies for solid tumor cancers presents a myriad of challenges.
April 14, 2023
Ginkgo Bioworks has acquired StrideBio's AAV capsid discovery and engineering platform and has formed a partnership with WARF for development of next-gen cell therapies.
April 12, 2023
Forecyte Bio has opened a new GMP facility in Shanghai just two months after its sister site in the United States.
April 05, 2023
Sartorius’ acquisition of Polyplus is designed to strengthen its cell and gene therapy capabilities.